BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24829088)

  • 21. The impact of the repair of staple line dehiscence in post-RYGB patients on glucose homeostasis and gut hormones--a preliminary study.
    Durczynski A; Szymanski D; Nowicki M; Hogendorf P; Wojciechowska-Durczyńska K; Czupryniak L; Strzelczyk J
    Endokrynol Pol; 2013; 64(1):7-12. PubMed ID: 23450441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.
    Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Jacobsen SH; Clausen TR; Worm D; Hartmann B; Rehfeld JF; Damgaard M; Madsen JL; Madsbad S; Holst JJ; Hansen DL
    Int J Obes (Lond); 2013 Nov; 37(11):1452-9. PubMed ID: 23419600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of variations in duodenal glucose load on glycemic, insulinemic, and incretin responses in healthy young and older subjects.
    Trahair LG; Horowitz M; Rayner CK; Gentilcore D; Lange K; Wishart JM; Jones KL
    J Clin Endocrinol Metab; 2012 Mar; 97(3):844-51. PubMed ID: 22238398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels.
    Lindqvist A; Ekelund M; Pierzynowski S; Groop L; Hedenbro J; Wierup N
    Peptides; 2017 Apr; 90():78-82. PubMed ID: 28242256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of small intestinal glucose on glycaemia, insulinaemia and incretin hormone release are load-dependent in obese subjects.
    Trahair LG; Marathe CS; Standfield S; Rayner CK; Feinle-Bisset C; Horowitz M; Jones KL
    Int J Obes (Lond); 2017 Feb; 41(2):225-232. PubMed ID: 27840416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of physiological hyperglycemia on duodenal motility and flow events, glucose absorption, and incretin secretion in healthy humans.
    Kuo P; Wishart JM; Bellon M; Smout AJ; Holloway RH; Fraser RJ; Horowitz M; Jones KL; Rayner CK
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3893-900. PubMed ID: 20501683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in Alimentary Glucose Absorption and Intestinal Disposal of Blood Glucose After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.
    Cavin JB; Couvelard A; Lebtahi R; Ducroc R; Arapis K; Voitellier E; Cluzeaud F; Gillard L; Hourseau M; Mikail N; Ribeiro-Parenti L; Kapel N; Marmuse JP; Bado A; Le Gall M
    Gastroenterology; 2016 Feb; 150(2):454-64.e9. PubMed ID: 26481855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction.
    Rabiee A; Magruder JT; Salas-Carrillo R; Carlson O; Egan JM; Askin FB; Elahi D; Andersen DK
    J Surg Res; 2011 May; 167(2):199-205. PubMed ID: 21414635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of metoclopramide on duodenal motility and flow events, glucose absorption, and incretin hormone release in response to intraduodenal glucose infusion.
    Kuo P; Bellon M; Wishart J; Smout AJ; Holloway RH; Fraser RJ; Horowitz M; Jones KL; Rayner CK
    Am J Physiol Gastrointest Liver Physiol; 2010 Dec; 299(6):G1326-33. PubMed ID: 20829521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men.
    Matikainen N; Söderlund S; Björnson E; Bogl LH; Pietiläinen KH; Hakkarainen A; Lundbom N; Eliasson B; Räsänen SM; Rivellese A; Patti L; Prinster A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
    Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):534-542. PubMed ID: 28428027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postprandial metabolite profiles reveal differential nutrient handling after bariatric surgery compared with matched caloric restriction.
    Khoo CM; Muehlbauer MJ; Stevens RD; Pamuklar Z; Chen J; Newgard CB; Torquati A
    Ann Surg; 2014 Apr; 259(4):687-93. PubMed ID: 23787216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roux-en-Y gastric bypass attenuates the progression of cardiometabolic complications in obese diabetic rats via alteration in gastrointestinal hormones.
    Lau RG; Kumar S; Hall CE; Palaia T; Rideout DA; Hall K; Brathwaite CE; Ragolia L
    Surg Obes Relat Dis; 2015; 11(5):1044-53. PubMed ID: 25980330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses.
    Little TJ; Pilichiewicz AN; Russo A; Phillips L; Jones KL; Nauck MA; Wishart J; Horowitz M; Feinle-Bisset C
    J Clin Endocrinol Metab; 2006 May; 91(5):1916-23. PubMed ID: 16492694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia.
    Toft-Nielsen M; Madsbad S; Holst JJ
    Diabetologia; 1998 Oct; 41(10):1180-6. PubMed ID: 9794105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide cell numbers in the super-obese human foregut after gastric bypass.
    Nergård BJ; Lindqvist A; Gislason HG; Groop L; Ekelund M; Wierup N; Hedenbro JL
    Surg Obes Relat Dis; 2015; 11(6):1237-46. PubMed ID: 26143297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery.
    Werling M; Vincent RP; Cross GF; Marschall HU; Fändriks L; Lönroth H; Taylor DR; Alaghband-Zadeh J; Olbers T; Le Roux CW
    Scand J Gastroenterol; 2013 Nov; 48(11):1257-64. PubMed ID: 24044585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and pathophysiology of early dumping in patients after primary Roux-en-Y gastric bypass during a mixed-meal tolerance test.
    Wijma RB; Emous M; van den Broek M; Laskewitz A; Kobold ACM; van Beek AP
    Surg Obes Relat Dis; 2019 Jan; 15(1):73-81. PubMed ID: 30446401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Customization of biliopancreatic limb length to modulate and sustain antidiabetic effect of gastric bypass surgery.
    Pal A; Rhoads DB; Tavakkoli A
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G287-G299. PubMed ID: 29097359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study.
    Kar P; Cousins CE; Annink CE; Jones KL; Chapman MJ; Meier JJ; Nauck MA; Horowitz M; Deane AM
    Crit Care; 2015 Jan; 19(1):20. PubMed ID: 25613747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.